Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, June 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 145 articles: HTML format

Single Articles

1. XU J, Wei G, Wang J, Wang H, et al
   Milk extracellular vesicles attenuate pre-inflammatory bowel disease via Lctobacillus murinus-mediated TLR2 signaling modulation.
   Cell Rep. 2026;45:117438.
   PubMed    
   Abstract available
   
   

2. VASANT DH, Kinsinger SW
   Evidence That Remote Group Gut-Directed Hypnotherapy Is Feasible and Effective-Positive Implications for Integrated Irritable Bowel Syndrome Care.
   Neurogastroenterol Motil. 2026;38:e70364.
   PubMed    
   
   
   

3. HEATH MR, Abber SR, Luo Y
   Beyond the Gut: How to Integrate Psychological Screening Into the Standard of Care for Irritable Bowel Syndrome?
   Neurogastroenterol Motil. 2026;38:e70345.
   PubMed    
   
   
   

4. MAJOR J, Vargay A, Adam S
   School-Related Stressors, Pain Outcome Measures and Extremely Low Health-Related Quality of Life in a Representative Sample of Hungarian Adolescents With Functional Abdominal Pain Disorders.
   Int J Pediatr. 2026;2026:9964179.
   PubMed    
   Abstract available
   
   

5. QALAWA SAA, Elbqry MG, Elmansy FM, Almunif AT, et al
   Dietary habits and their association with irritable bowel syndrome among the public population in Saudi Arabia: a multicenter based study.
   Front Public Health. 2026;14:1804238.
   PubMed    
   Abstract available
   
   

6. MORA GUZMAN Z, Bazan Salinas IL, Moreno-Cabral S, Perez-Campos E, et al
   Probiotics in irritable bowel syndrome: strain-specific effects, diet, and biomarker timing.
   Front Cell Infect Microbiol. 2026;16:1794927.
   PubMed    
   
   
   

7. CHOI Y, Ha NY, Kim AR, Kwon O, et al
   Efficacy and safety of modified Gwakjeongtang (herbal medicine) for diarrhea-predominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial.
   Integr Med Res. 2026;15.
   PubMed    
   Abstract available
   
   

8. IZIMA C, Khan FA, Ayloo B, Fuller JS, et al
   Irritable bowel syndrome and its impact on utilization and outcomes in elective thoracolumbar fusion.
   Brain Spine. 2026;6:106087.
   PubMed    
   Abstract available
   
   

9. DENG LX, Almario CV, Lai JC, Spiegel BMR, et al
   Characterizing Abdominal Pain and Irritable Bowel Syndrome Among Individuals With Cirrhosis: Results of a Nationwide Survey.
   Gastro Hep Adv. 2026;5:100976.
   PubMed    
   
   
   

10. PRASAD S, Nagda J, Ahuja A, Agrawal S, et al
    ACE inhibitor-induced isolated intestinal angioedema mimicking functional bowel disorder: a case report.
    BMC Gastroenterol. 2026 May 27. doi: 10.1186/s12876-026-04935.
    PubMed    
    Abstract available
    
    

11. ZHANG Y, Gao L, Zhang X, Sun W, et al
    Application of neuromodulation techniques in irritable bowel syndrome.
    Front Neurosci. 2026;20:1792685.
    PubMed    
    Abstract available
    
    

12. SONG S, Han M, Moon K, Lee H, et al
    Bifidobacterium stercoris KC84 attenuates IBS-D-like symptoms via modulation of serotonin-related pathways and dendritic cell-mediated IFN-beta induction.
    Curr Res Microb Sci. 2026;10:100603.
    PubMed    
    Abstract available
    
    

13. PASTRAS P, Aggeletopoulou I, Psalti V, Triantos C, et al
    Gut Microbiota in Irritable Bowel Syndrome and Inflammatory Bowel Disease: Differences in Pathophysiology, Biomarkers, and Treatment Implications.
    Pharmaceuticals (Basel). 2026;19:783.
    PubMed    
    Abstract available
    
    

14. MOTOYAMA M, Yamada H, Yoshimura C, Matsunaga H, et al
    Clinical Utility of Anti-Gliadin IgG Antibody (AGA IgG) and Characterization of Patients with Suspected Non-Celiac Gluten Sensitivity: Prospective, Observational Study in Japan.
    Nutrients. 2026;18:1607.
    PubMed    
    Abstract available
    
    

15. LAMBIASE C, Cancelli L, Tedeschi R, Grosso A, et al
    Effects of gamma-Aminobutyric Acid (GABA) Supplementation on Symptoms, Quality of Life, Intestinal Permeability, Systemic Inflammation and Gut Microbiota in Patients with IBS-D: A Randomized, Double Blind, Placebo-Controlled, Crossover Pilot Study.
    Nutrients. 2026;18:1569.
    PubMed    
    Abstract available
    
    

16. DEMIRCI FK, Koca TG, Elmas A, Akcam M, et al
    Sucrase-Isomaltase Deficiency in Children with Functional Gastrointestinal Disorders.
    J Clin Med. 2026;15:3639.
    PubMed    
    Abstract available
    
    

17. BAE Y, Seo S, Jeon SR, Dong JJ, et al
    Long-Term Risk of Parkinson's Disease Following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study.
    Healthcare (Basel). 2026;14:1329.
    PubMed    
    Abstract available
    
    

18. CANDREA AR, Gavrilas LI, Mocan A, Rusu A, et al
    Comparative Analysis of Gut Microbiota Patterns in Irritable Bowel Syndrome, Anxiety, and Autoimmune Disorders.
    Biomedicines. 2026;14:1005.
    PubMed    
    Abstract available
    
    

19. STEEN OD, Ohlsson H, van Ockenburg SL, Kendler KS, et al
    Shared genetic risk between functional somatic syndromes, internalizing disorders, and immune-mediated diseases: a twin-sibling study.
    Brain Behav Immun. 2026;137:106837.
    PubMed    
    Abstract available
    
    

20. MILLOVICH V, Shingara IO, Lopes GS, Tyagi M, et al
    Comparing characteristics and outcomes between hospitalized adults on a pea protein or dairy/soy protein formulas: initial findings.
    J Comp Eff Res. 2026 May 26:e260035. doi: 10.57264/cer-2026-0035.
    PubMed    
    Abstract available
    
    

21. ZHEN J, Zhou Z, Zhu R, Kuang M, et al
    Research Progress on the Role of Lactobacillus reuteri in Irritable Bowel Syndrome: A Review.
    Biology (Basel). 2026;15:808.
    PubMed    
    Abstract available
    
    

22. ATANASOVA K, Mellein S, Knoedler LL, Niehaus VD, et al
    Gastrointestinal-specific Anxiety in IBD: Associations with Disease Activity, Psychological Symptoms, and Serotonergic Polymorphisms.
    Biopsychosoc Sci Med. 2026 May 26. doi: 10.1097/PSY.0000000000001493.
    PubMed    
    Abstract available
    
    

23. ABDELAZIZ MN, Abdallah O, Bshar AM, Alqenawy M, et al
    Cardiometabolic Burden of Irritable Bowel Syndrome: A Case-Control Analysis of Metabolic Syndrome Clustering.
    J Epidemiol Glob Health. 2026;16:64.
    PubMed    
    Abstract available
    
    

24. CHEN X, Wang Y, Hou Y, Zhang L, et al
    Distinct psychophysiological biomarkers and risk stratification models for irritable bowel syndrome with constipation (IBS-C) and diarrhea (IBS-D).
    Sci Rep. 2026 May 25. doi: 10.1038/s41598-026-50456.
    PubMed    
    Abstract available
    
    

25. ANG D
    Irritable bowel syndrome management: current insights.
    Singapore Med J. 2026;67:309-313.
    PubMed    
    
    
    

26. ALSAUD AS, Aldoweesh OH, Aljurayyed SM, Alharbi FB, et al
    Association between eating disorders and functional gastrointestinal disorders: a systematic review.
    Front Psychol. 2026;17:1785045.
    PubMed    
    Abstract available
    
    

27. LI Q, Mo JH, Chen HQ, Chen MX, et al
    Translation, cross-cultural adaptation and validation of the Chinese version of irritable bowel syndrome severity scoring system.
    Front Med (Lausanne). 2026;13:1779402.
    PubMed    
    Abstract available
    
    

28. KUBATKA P, Kapinova A, Bojkova B, Joseph V, et al
    From sympathetic overdrive phenotype to malignant transformation: 3PM-guided protection against health-to-disease transition and disease progression improving individual outcomes in primary and secondary care.
    EPMA J. 2026;17:205-232.
    PubMed    
    Abstract available
    
    

29. WANG X, Wei Y, Wang M, Zhang Y, et al
    Deciphering the multi-target mechanism of Magnolia officinalis in irritable bowel syndrome with diarrhea: A combined network pharmacology, machine learning, and in vivo validation study.
    Biochem Biophys Res Commun. 2026;825:153989.
    PubMed    
    Abstract available
    
    

30. ALGHAMDI F, Alqarni AM, Alzahrani MA, Alzahrani OM, et al
    Knowledge, Awareness, and Practices Toward Irritable Bowel Syndrome (IBS) Among the General Population in the Al-Baha Region, Saudi Arabia.
    Cureus. 2026;18:e108208.
    PubMed    
    Abstract available
    
    

31. CHEN J, Li A, Wu W, Xu W, et al
    Gut microbiota signatures differentiate trajectory-defined response phenotypes and predict self-management outcomes in irritable bowel syndrome.
    medRxiv [Preprint]. 2026 May 20:2026.05.18.26353470.
    PubMed    
    Abstract available
    
    

32. VALIENTE-GOMEZ A, Bucker J, Fontana-McNally M, Gatto DL, et al
    Adverse childhood experiences and risk of non-mental medical diseases in adulthood: an umbrella review.
    EClinicalMedicine. 2026;96:103987.
    PubMed    
    Abstract available
    
    

33. SONSALLA SG, Armbruster-Lee J, Samarasinghe AE
    Importance of vitamin D in gastrointestinal health and disease.
    Front Nutr. 2026;13:1807154.
    PubMed    
    Abstract available
    
    

34. KE H, Chen W, Zhang Q, Liu Z, et al
    Multi-omics mendelian randomization integrating GWAS and eQTL data revealed potential drug target for irritable bowel syndrome.
    Front Genet. 2026;17:1798264.
    PubMed    
    Abstract available
    
    

35. WANG TJ, Serrano-Ardila AM
    Comorbidities in Ehlers-Danlos syndromes and hypermobile spectrum disorders.
    Acta Ortop Mex. 2026;40:85-88.
    PubMed    
    Abstract available
    
    

36. LEE KD, Nagasako Y
    Coexisting Non-inflammatory Fibrotic Entrapment and Traumatic Neuroma as Distinct Mechanisms of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES) Following Laparoscopic Percutaneous Extraperitoneal Closure (LPEC) in a Child.
    Cureus. 2026;18:e108070.
    PubMed    
    Abstract available
    
    

37. DENS K, Van Den Houte M, Tack J, Toelen J, et al
    Bodily Maps of Emotions in Irritable Bowel Syndrome: A Case-Control Study.
    Neurogastroenterol Motil. 2026;38:e70366.
    PubMed    
    Abstract available
    
    

38. LI L, Zhuang Y, Ran Y, Wang L, et al
    Nonlinear association between composite dietary antioxidant index and irritable bowel syndrome: insights from UK Biobank.
    BMC Public Health. 2026 Jun 1. doi: 10.1186/s12889-026-27996.
    PubMed    
    Abstract available
    
    

39. YE W, Ding H, Peng B, Wang X, et al
    Large-scale meta- and cross-trait analyses uncover shared genetic risk factors for IBS and psychiatric disorders.
    Front Psychiatry. 2026;17:1795532.
    PubMed    
    Abstract available
    
    

40. YUAN J, Chen X, Wang J, Luo J, et al
    Association between healthy lifestyle factors and risk of chronic diarrhea: A cross-sectional study using NHANES 2007 to 2010 data.
    Medicine (Baltimore). 2026;105:e49045.
    PubMed    
    Abstract available
    
    

41. SHAH ED, Sharma A, Curren N, Laitman AP, et al
    Irritable Bowel Syndrome with Constipation: Diagnosis and Multisymptom Management Beyond Abdominal Pain and Bowel Movement Frequency: A Review.
    Adv Ther. 2026 Jun 12. doi: 10.1007/s12325-026-03645.
    PubMed    
    Abstract available
    
    

42. KOU Z, Li R, Wang J, Shao Z, et al
    Residential green space mitigates genetic susceptibility to incident irritable bowel syndrome in a prospective cohort of 376 749 individuals.
    J Glob Health. 2026;16:04169.
    PubMed    
    Abstract available
    
    

43. WANG Y, Chu F, Gong Y, Guo R, et al
    Monosodium glutamate-mediated Ca(2+)-dependent intestinal epithelial ion transports in health and IBS-D in male mice.
    Physiol Rep. 2026;14:e70975.
    PubMed    
    Abstract available
    
    

44. ALOSTA S, Fataftah N, Makhamreh MF, Abu Shaker I, et al
    Sociodemographic Characteristics and Comorbidities of Primary Fibromyalgia: A Cross-Sectional Study.
    Inquiry. 2026;63:469580261452225.
    PubMed    
    Abstract available
    
    

45. LIMKETKAI BN, Shin A, Manitius N, Rau S, et al
    Dietary Therapies for Gastrointestinal Disorders.
    Nutrients. 2026;18:1787.
    PubMed    
    Abstract available
    
    

46. SOLTANI-MOGHADAM F, Kafil HS, Sefidan FY, Nezhadi J, et al
    Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases.
    Curr Microbiol. 2026;83:414.
    PubMed    
    Abstract available
    
    

47. YANG W, Bian S, Tan H
    Therapeutic potential of Lachnospiraceae strains in irritable bowel syndrome via differential gut-brain pathways.
    Microbiome Res Rep. 2026;5:12.
    PubMed    
    Abstract available
    
    

48. BUTT MF, Reghefaoui M, Bush D, Aliyu A, et al
    Outcomes for a digital prescription mobile application for adults with irritable bowel syndrome: an uncontrolled trial.
    BMC Gastroenterol. 2026 Jun 11. doi: 10.1186/s12876-026-04964.
    PubMed    
    Abstract available
    
    

49. STEINERT RE, Van den Abbeele P, Schaefer C, Poppe J, et al
    Carotenoids modulate fermentation of inulin ex vivo in IBS and overweight adult gut microbiota.
    BMC Microbiol. 2026 Jun 10. doi: 10.1186/s12866-026-05271.
    PubMed    
    Abstract available
    
    

50. TANG M, Gou L, Bao W, Lei J, et al
    Maternal vitamin A deficiency programs offspring visceral hypersensitivity through RARbeta-COX-2/PGE2 signaling.
    Biochim Biophys Acta Mol Cell Biol Lipids. 2026 Jun 10:159749.
    PubMed    
    Abstract available
    
    

51. SKELTON M, Mitchell BL, Assary E, Li D, et al
    Genome-wide meta-analysis of quantitatively measured generalized anxiety symptoms in individuals of European ancestry.
    Nat Hum Behav. 2026 Jun 9. doi: 10.1038/s41562-026-02476.
    PubMed    
    Abstract available
    
    

52. FANG TY, Lin TT, Yang CS, Chiang HC, et al
    Acupuncture-like transcutaneous electrical nerve stimulation for patients with irritable bowel syndrome: Pilot mixed-methods study.
    J Bodyw Mov Ther. 2026;47:556-564.
    PubMed    
    Abstract available
    
    

53. GOLUBOVIC O, Knezevic Ivanovski T, Kralj D, Mitrovic M, et al
    Irritable Bowel Syndrome Prevalence in Patients with Inflammatory Bowel Disease in Remission: Single-Center Experience.
    Clin Exp Gastroenterol. 2026;19:582517.
    PubMed    
    Abstract available
    
    

54. ATALAR K, Alim E, Calikusu A, Abbasoglu Topa EG, et al
    tVNS Mitigates Neuroinflammation and Nociception in a Rodent LPS Endotoxemia Model.
    Clin Transl Sci. 2026;19:e70633.
    PubMed    
    Abstract available
    
    

55. CHOI WG, Choi NR, Jung D, Kim SC, et al
    Rikkunshito ameliorates colonic dysfunction and hormonal imbalance in an IBS mouse model with modulation of transient receptor potential channel activity.
    Front Pharmacol. 2026;17:1813619.
    PubMed    
    Abstract available
    
    

56. 
    Erratum: Review of the Patient Burden and Therapeutic Landscape of Irritable Bowel Syndrome with Constipation in the United States [Corrigendum].
    Clin Exp Gastroenterol. 2026;19:618800.
    PubMed    
    Abstract available
    
    

57. ARIF L, Abbasi MM, Raza AA, Samadi A, et al
    From microbiome profiling to precision medicine: diagnostic and therapeutic potential in gastrointestinal disorders: current evidence, challenges, and future directions.
    Ann Med Surg (Lond). 2026;88:3348-3359.
    PubMed    
    Abstract available
    
    

58. RIBET L, Dessalles R, Clement H, Nyhan L, et al
    Fermentation in breadmaking: enhancing digestibility and nutritional value for gastrointestinal health.
    Front Nutr. 2026;13:1777596.
    PubMed    
    Abstract available
    
    

59. 
    Correction to: Long-Term Safety of Tenapanor in Patients With Irritable Bowel Syndrome With Constipation in the T3MPO-3 Study.
    Neurogastroenterol Motil. 2026;38:e70346.
    PubMed    
    
    
    

60. SHEN B, Zhang HH, Wang C, Xu X, et al
    Targeting P2X receptor signaling for chronic visceral pain and beyond.
    Neuropharmacology. 2026 Jun 4:111049. doi: 10.1016/j.neuropharm.2026.111049.
    PubMed    
    Abstract available
    
    

61. NGUYEN L, Pierce SJ, Barnett KA, Cunningham NR, et al
    The Impact of a Cognitive Behavioral Therapy Program for Pediatric Patients With Disorders of Gut-Brain Interaction and Co-Occurring Mental Health Diagnoses.
    Acad Pediatr. 2026;26:103257.
    PubMed    
    Abstract available
    
    

62. CANGEMI DJ, Laitman AP, Faiman O, Chang BW, et al
    Constipation with bloating: a clinical approach to evaluation and management.
    Ann Med. 2026;58:2684172.
    PubMed    
    Abstract available
    
    

63. ANDAFA TW, Imoh EC, Adekanmbi SA
    Artificial Intelligence Applied to the Brain-Gut Axis in Irritable Bowel Syndrome: Advancing Toward Clinical Translation.
    Cureus. 2026;18:e109142.
    PubMed    
    Abstract available
    
    

64. YUE R, Wen Y, Zhao S, Liu X, et al
    Tea and digestive system health: integrating gut microbiota-involved ADME and personalized nutrition for gastrointestinal disorders intervention.
    Crit Rev Food Sci Nutr. 2026 Jun 19:1-34. doi: 10.1080/10408398.2026.2684712.
    PubMed    
    Abstract available
    
    

65. ZHANG L, Chu F, Wan H, Dong H, et al
    Dysfunction in the SOCE/EDH-mediated vasorelaxation of mesenteric arteries impairs intestinal barrier integrity in irritable bowel syndrome.
    Biochem Pharmacol. 2026 Jun 18:118179. doi: 10.1016/j.bcp.2026.118179.
    PubMed    
    Abstract available
    
    

66. DOS SANTOS SILVA L, Faro A, Mosterd D
    Effectiveness of self-administered and minimal-contact psychotherapy in reducing irritable bowel syndrome symptom severity: a systematic review.
    Psychol Health Med. 2026 Jun 18:1-25. doi: 10.1080/13548506.2026.2691407.
    PubMed    
    Abstract available
    
    

67. DING H, Chen S, Xie F, Cao C, et al
    The Association Between Childhood Maltreatment and Adult Intestinal Disorders: A Three-Level Meta-Analysis.
    Trauma Violence Abuse. 2026 Jun 18:15248380261460029.
    PubMed    
    Abstract available
    
    

68. MORRISON S, Talley N
    Diagnosis and management of irritable bowel syndrome.
    Aust Prescr. 2026;49:93-98.
    PubMed    
    Abstract available
    
    

69. ROSSI CM, Lenti MV, Di Sabatino A
    Any role for respiratory allergens in IBS symptoms? From pathogenetic hypothesis to therapeutic implications.
    Front Allergy. 2026;7:1844274.
    PubMed    
    Abstract available
    
    

70. BITZER E, Bourke P, Hussain S
    MEAT PIES: Mammalian Meat Allergy in Patients Investigated for Gastrointestinal Symptoms: Detection of Mammalian Meat Allergy in the Gastroenterology Outpatient Department, Cairns Hospital, Queensland, Australia.
    JGH Open. 2026;10:e70433.
    PubMed    
    Abstract available
    
    

71. IFTEQUAR Y, Bajpai P, Dav R, Harshitha KS, et al
    Targeted antibiotic and dietary approaches in managing small intestinal bacterial overgrowth across irritable bowel syndrome subtypes.
    Intern Emerg Med. 2026 Jun 17. doi: 10.1007/s11739-026-04418.
    PubMed    
    Abstract available
    
    

72. OW PL, Wright-Hughes A, Everitt HA, Farrin AJ, et al
    Belief of Allocated Treatment and Symptom Response to Amitriptyline in Irritable Bowel Syndrome.
    Clin Gastroenterol Hepatol. 2026 Jun 17:S1542-3565(26)00472.
    PubMed    
    
    
    

73. XIE X, Yan W, Zhang X, Gan C, et al
    FMT from IBS-D Rats Impairs Intestinal Barrier Function and is Associated with Increased Intestinal Benzoic Acid and Ruminococcus Abundance.
    J Microbiol Biotechnol. 2026;36:e2602004.
    PubMed    
    Abstract available
    
    

74. SCARPELLINI E, Roselli F, Scarcella M, Tedesco C, et al
    Guar Gum, Partially Hydrolyzed Guar Gum, and Human Gut Health: A Narrative Review.
    Rev Recent Clin Trials. 2026 Jun 12. doi: 10.2174/0115748871483178260603111726.
    PubMed    
    Abstract available
    
    

75. SPAGNOLO G, Ferrarese D, DI Vincenzo F, Iaccarino J, et al
    Neurofeedback as a non-pharmacological strategy for pain and gut-brain axis disorders: clinical relevance in inflammatory bowel disease.
    Minerva Gastroenterol (Torino). 2026 Jun 17. doi: 10.23736/S2724-5985.26.04026.
    PubMed    
    Abstract available
    
    

76. PAVIC AM, Ruska P, Misak Z, Krbot Skoric M, et al
    Gastric myoelectrical activity and autonomic dysfunction in children with IBD and IBS: An electrogastrographic and autonomic correlation study.
    Auton Neurosci. 2026;266:103449.
    PubMed    
    Abstract available
    
    

77. LIN Z, Mo G, Wang Y, Lin S, et al
    Genomic Research for Abdominal Pain in Patients with Irritable Bowel Syndrome or Inflammatory Bowel Disease Before and After Mind-Body Intervention.
    J Pain Res. 2026;19:605236.
    PubMed    
    Abstract available
    
    

78. YAN Q, Li M, Wang G, Zhang A, et al
    Cross-kingdom microbial associations characterize responsiveness to fecal microbiota transplantation in patients with irritable bowel syndrome.
    J Transl Med. 2026 Jun 15. doi: 10.1186/s12967-026-08269.
    PubMed    
    Abstract available
    
    

79. QU Y, Zhang Y, Zhou S, Yang T, et al
    Enteric neuroimmune interactions in health and disease.
    Trends Neurosci. 2026 Jun 15:S0166-2236(26)00114.
    PubMed    
    Abstract available
    
    

80. SHIHA MG, Buckle RL, Shaw CC, Aziz I, et al
    Low FODMAP Diet versus Traditional Dietary Advice in Postprandial Functional Dyspepsia: A Randomized Clinical Trial.
    Clin Gastroenterol Hepatol. 2026 Jun 15:S1542-3565(26)00440.
    PubMed    
    Abstract available
    
    

81. MAYUR D, Agarwal A, Birda CL, Gogineni VC, et al
    Prevalence and predictors of coeliac disease in patients with irritable bowel syndrome: A prospective study from Rajasthan, India.
    Trop Doct. 2026 Jun 15:494755261459504. doi: 10.1177/00494755261459504.
    PubMed    
    Abstract available
    
    

82. UKASHI O, Tzur M, Yablecovitch D, Lahat A, et al
    Immune-based personalized elimination diet for the treatment of irritable bowel syndrome: a double-blind randomized sham-controlled study.
    Gastroenterol Rep (Oxf). 2026;14:goag058.
    PubMed    
    Abstract available
    
    

83. ZHOU Y, Li Z, Chu Y, Zhou Z, et al
    Reframing precision nutrition in irritable bowel syndrome: a mechanism-informed conceptual framework for responder prediction and clinical translation.
    Front Immunol. 2026;17:1809221.
    PubMed    
    Abstract available
    
    

84. MAQSOOD A, Fatima SK, Kumar S, Moni MM, et al
    Primary Bile Acid Diarrhea: A Narrative Review of Pathophysiology, Diagnostic Challenges, and Emerging Therapeutic Strategies.
    Cureus. 2026;18:e108847.
    PubMed    
    Abstract available
    
    

85. HOANG T, Kim J
    Efficacy and Safety of Probiotics, Prebiotics, and Synbiotics: An Umbrella Review of Systematic Reviews and Meta-Analysis of Randomized Controlled Trials.
    Nutr Rev. 2026 Jun 15:nuaf303. doi: 10.1093.
    PubMed    
    Abstract available
    
    

86. WU J, He J, Zhang K, Liu X, et al
    Phocaeicola vulgatus improves anxiety-like behavior by ameliorating amygdala neuroinflammation and the neurite impairment in IBS.
    Transl Psychiatry. 2026 Jun 15. doi: 10.1038/s41398-026-04142.
    PubMed    
    Abstract available
    
    

87. YONEDA H, Tomita T, Kitano T, Morishita D, et al
    Magnesium-Rich Mineral Water Improves Stool Consistency and Bowel Habits in Healthy Subjects: A Randomized Controlled Trial.
    Neurogastroenterol Motil. 2026;38:e70378.
    PubMed    
    Abstract available
    
    

88. YING Y, Zheng X, Yang J, Ye H, et al
    Tong-Xie-Yao-Fang Ameliorates IBS-D: Potential Role of Alistipes finegoldii-associated Gut Tryptophan Indole Metabolism.
    J Ethnopharmacol. 2026 Jun 26:122061. doi: 10.1016/j.jep.2026.122061.
    PubMed    
    Abstract available
    
    

89. MORLEY S, Utter J
    Dietary management of functional bowel disorders in outpatient clinics: A retrospective audit.
    Nutr Health. 2026 Jun 26:2601060261462770. doi: 10.1177/02601060261462770.
    PubMed    
    Abstract available
    
    

90. WU L, Fang J, Chen M, Si YC, et al
    Acupuncture modulates the microbiota-gut-brain axis to treat irritable bowel syndrome: a mechanistic exploration.
    Front Neurosci. 2026;20:1820371.
    PubMed    
    Abstract available
    
    

91. LI H, Ye A, Song J, Yang Y, et al
    The gut microbiota-enteric nervous system axis: from bidirectional programming to precision therapeutics in digestive diseases.
    Front Cell Infect Microbiol. 2026;16:1852596.
    PubMed    
    Abstract available
    
    

92. CALABRESE FM, Bianco A, Chiarini M, Prospero L, et al
    GPCS Stratification of Exercise-Induced Gut Microbiota and Metabolome Remodeling in IBS: An Exploratory Multi-Omics Study.
    Nutrients. 2026;18:1972.
    PubMed    
    Abstract available
    
    

93. CIUREA NA, Mahdi L, Graziani A, Di Ciaula A, et al
    Targeting the Human Gut Microbiota-Between Conventional Therapy and Precision Genetic Engineering.
    Nutrients. 2026;18:1958.
    PubMed    
    Abstract available
    
    

94. D'INCAU E, Kaplan CM, Micoulaud-Franchi JA, Veasley C, et al
    Multimorbidity in Chronic Overlapping Pain Conditions: From Burden to Integrated Care.
    J Clin Med. 2026;15:4835.
    PubMed    
    Abstract available
    
    

95. YOUSEF A, Wang N, Yousef M, Elfert K, et al
    Evaluating the Risk of Clostridioides difficile Infection After Rifaximin Treatment for Small Intestinal Bacterial Overgrowth.
    J Clin Med. 2026;15:4449.
    PubMed    
    Abstract available
    
    

96. STORR M, Gschwender M
    Viable and Heat-Inactivated Bifidobacterium bifidum MIMBb75 Protect the Intestinal Barrier.
    Microorganisms. 2026;14:1349.
    PubMed    
    Abstract available
    
    

97. OTHMAN G, El Sayed Zaki M, Elmalki Elmalki N, Badawy AA, et al
    Non-Invasive Multimarker Strategy Combining IL-17A, Neutrophil-Albumin Ratio, and Fecal Calprotectin for Accurate Discrimination of IBD from IBS-D.
    Int J Mol Sci. 2026;27:5450.
    PubMed    
    Abstract available
    
    

98. SUN Q, Gao Y, Shi X, Xie M, et al
    Irritable bowel syndrome subtype predicts treatment response and defines distinct mechanistic phenotypes in OAB-IBS comorbidity: a prospective observational study.
    World J Urol. 2026;44:461.
    PubMed    
    Abstract available
    
    

99. PENG W, Xu T, Zhang Z, Cui L, et al
    Study on the therapeutic effects of the primary active ingredients in cinnamon oil for constipation-predominant irritable bowel syndrome and their regulatory effects on the 5-HT signaling pathway and gut microbiota.
    Naunyn Schmiedebergs Arch Pharmacol. 2026.
    PubMed    
    Abstract available
    
    

100. THAKUR ER, Brenes GA, Keefer L
     Editorial: Bodily Maps of Emotions in Irritable Bowel Syndrome-Implications for Brain-Gut and Gut-Brain Interventions.
     Neurogastroenterol Motil. 2026;38:e70385.
     PubMed    
     
     
     

101. MASLENNIKOV R, Agarkova V, Poluektova E, Ulyanin A, et al
     Treatment of Small Intestinal Bacterial Overgrowth (SIBO) in Gastrointestinal, Hepatic, Endocrine, Neurological, and Postoperative Diseases: A Comprehensive Narrative Review.
     Med Sci (Basel). 2026;14:300.
     PubMed    
     Abstract available
     
     

102. CHANG X, Wang L, Zhang L, Yang Z, et al
     [Mechanism of electroacupuncture at "Tianshu" (ST25) and "Dachangshu" (BL25) for attenuating visceral hypersensitivity in rats with post-inflammatory irritable bowel syndrome based on transcriptome sequencing technology].
     Zhongguo Zhen Jiu. 2026;46:970-978.
     PubMed    
     Abstract available
     
     

103. SONG Z, Zhou K, Liang G, Liu Y, et al
     Bidirectional Communication of the Gut-Brain Axis in Pain Regulation: From Microbial Metabolites to Neuroinflammation.
     J Inflamm Res. 2026;19:614847.
     PubMed    
     Abstract available
     
     

104. ABRUZZESE V, Biskou O, Winberg ME, Israelsen H, et al
     ReFerm(R) a Fermented Oat Gruel Composition, Improves Colonic Barrier Function and Modulates Tricellulin Expression in Patients With Irritable Bowel Syndrome.
     Neurogastroenterol Motil. 2026;38:e70381.
     PubMed    
     Abstract available
     
     

105. MERZAEI Z, Kazemian H, Bamzadeh Z, Paknejadi M, et al
     Association of IBS-associated E. coli strains with epithelial inflammatory responses and tight junction dysregulation in Caco-2 cells.
     BMC Res Notes. 2026 Jun 23. doi: 10.1186/s13104-026-07924.
     PubMed    
     Abstract available
     
     

106. ARRIZABALO S, Banegas K, Velasco-Benitez CA, Velasco-Suarez DA, et al
     Menstrual-Associated Gastrointestinal Symptoms and Their Impact on IBS Diagnosis in Adolescents.
     Neurogastroenterol Motil. 2026;38:e70382.
     PubMed    
     Abstract available
     
     

107. KHADIV A, Yazdanmanesh M, Heidari H, Yazdani F, et al
     Widespread adhesion and iron acquisition traits in Escherichia coli strains obtained from irritable bowel syndrome (IBS) patients.
     BMC Res Notes. 2026 Jun 22. doi: 10.1186/s13104-026-07922.
     PubMed    
     Abstract available
     
     

108. WHELAN K
     Human clinical trials of probiotics: a call to improve study design, conduct, and reporting.
     Adv Nutr. 2026 Jun 22:100691. doi: 10.1016/j.advnut.2026.100691.
     PubMed    
     
     
     

109. PAPARELLA G, Paparella G, Barone R, Lupia M, et al
     Irritable bowel syndrome is related to small fibre pathology in patients with fibromyalgia.
     Clin Exp Rheumatol. 2026;44:1177-1187.
     PubMed    
     Abstract available
     
     

110. COOK JD, Hounsell KG, Vidal AJ, Madakadze C, et al
     Chronic schistosomiasis and strongyloidiasis mimicking irritable bowel syndrome over multiple decades: A case report.
     Infect Dis Immun. 2025;5:219-222.
     PubMed    
     Abstract available
     
     

111. HONG SH, Jeong N, Park JW, Kim J, et al
     Trends and seasonal variation in the incidence and prevalence of irritable bowel syndrome in Korea: a multicenter OMOP CDM study.
     Front Public Health. 2026;14:1711919.
     PubMed    
     Abstract available
     
     

112. PEREZ-MANCHON D, Lozano-Hernandez CM, Mata-Gonzalez G, Arias-Arias AJ, et al
     Impact of nursing shift patterns on work-related gastrointestinal disorders: a systematic review and meta-analysis.
     Front Public Health. 2026;14:1839569.
     PubMed    
     Abstract available
     
     

113. TAO E
     Early life stress and the pathogenesis of visceral hypersensitivity: mechanisms and implications for disorders of gut-brain interaction.
     Front Cell Dev Biol. 2026;14:1827148.
     PubMed    
     Abstract available
     
     

114. BAI Y, Yu M, Weng C, Xu J, et al
     Autonomic nervous system dysfunction in irritable bowel syndrome: pathophysiology and therapeutic implications.
     Front Neurosci. 2026;20:1832540.
     PubMed    
     Abstract available
     
     

115. ZHANG J, Zhang S, Chen Z, Lai C, et al
     Co-fermentation of Rosa roxburghii Tratt pulp by Saccharomyces cerevisiae and Bacillus subtilis alleviates diarrhea-predominant irritable bowel syndrome in mice by reshaping gut microbiota and host metabolism.
     Front Nutr. 2026;13:1854409.
     PubMed    
     Abstract available
     
     

116. GROEN SR, Weerts ZZRM, Vork L, Mujagic Z, et al
     The Association Between Personality Traits and Irritable Bowel Syndrome-Insights From an Exploratory Cohort Study.
     Neurogastroenterol Motil. 2026;38:e70384.
     PubMed    
     Abstract available
     
     

117. BROWN M, Vernon SD, Indart AC, Green PH, et al
     Gastrointestinal symptoms correlate with core clinical features and systemic inflammation in myalgic encephalomyelitis/chronic fatigue syndrome.
     J Transl Med. 2026;24:813.
     PubMed    
     Abstract available
     
     

118. XU S, Lyu J, Bao G, Zheng P, et al
     Gut bacteria that produce fatty acid ethanolamides alleviate diarrhea-predominant IBS with insulin resistance.
     Cell Host Microbe. 2026 Jun 19:S1931-3128(26)00213.
     PubMed    
     Abstract available
     
     

119. LIAO FM, Chen YT, Shen SP, Jung CR, et al
     Risk factors and long-term outcomes of infantile colic: A nationwide population-based study.
     Sci Rep. 2026;16:4567.
     PubMed    
     Abstract available
     
     

120. ANDRADE TD, Rangan V, Ballou S
     The Impact of Age on Disorders of Gut-Brain Interaction.
     Clin Gastroenterol Hepatol. 2026;24:2031-2033.
     PubMed    
     Abstract available
     
     

121. VELDMAN F, Innocenti F, Aziz I, Fikree A, et al
     Prevalence and Burden of Fatigue Across Disorders of Gut-Brain Interaction: Results From the Rome Foundation Global Epidemiology Study.
     Aliment Pharmacol Ther. 2026 May 28. doi: 10.1111/apt.70756.
     PubMed    
     Abstract available
     
     

122. SHIHA MG, Keszthelyi D
     Letter: Low-FODMAP Diet in Irritable Bowel Syndrome-Beyond the Hype!
     Aliment Pharmacol Ther. 2026 Jun 12. doi: 10.1111/apt.70792.
     PubMed    
     
     
     

123. 
     Correction to 'Effects of a Personalised FODMAP Diet Versus the National Institute for Health and Care Excellence (NICE) Dietary Advice on Symptom Control in Patients With Irritable Bowel Syndrome: Randomised Clinical Trial'.
     Aliment Pharmacol Ther. 2026 Jun 11. doi: 10.1111/apt.70788.
     PubMed    
     
     
     

124. GARCIA-CEDILLO MF, la Torre MFH, Arenas-Martinez JS, Coss-Adame E, et al
     Letter: Low-FODMAP Diet in Irritable Bowel Syndrome-Beyond the Hype! Authors' Reply.
     Aliment Pharmacol Ther. 2026 Jun 19. doi: 10.1111/apt.70812.
     PubMed    
     
     
     

125. BLOMSTEN A, Trindade IA, Nybacka S, Melchior C, et al
     Avoidant/Restrictive Eating in People With and Without Bowel Symptoms in the General Population: Prevalence, Clinical Profile, and Associated Factors.
     Am J Gastroenterol. 2026;121:1473-1483.
     PubMed    
     Abstract available
     
     

126. ENGEL T, Faibis C, Tzur M, Carter D, et al
     Physician-patient discordance in Bristol stool scale classification and overall IBS burden assessment.
     Am J Gastroenterol. 2026 Jun 9. doi: 10.14309/ajg.0000000000004077.
     PubMed    
     Abstract available
     
     

127. VAN OUYTSEL P, Cremer A, Franchimont D, Liefferinckx C, et al
     Screening of Avoidance/Restrictive Food Intake Disorder (ARFID) in Patients with Quiescent Inflammatory Bowel Disease and Irritable Bowel Syndrome-Like Symptoms.
     Dig Dis Sci. 2026 Jun 22. doi: 10.1007/s10620-026-10067.
     PubMed    
     Abstract available
     
     

128. NISHIDA K, Hirata Y, Murano M, Mitooka H, et al
     Comparative Effectiveness of Hangeshashinto and Ramosetron for the Treatment of Irritable Bowel Syndrome with Diarrhea.
     Digestion. 2026 Jun 1:1-18. doi: 10.1159/000552817.
     PubMed    
     Abstract available
     
     

129. BURISCH J, Marsiglio M, Keszthelyi D
     Consensus on Irritable Bowel Syndrome-like Symptoms in Inflammatory Bowel Disease: A Step Toward Advancing Patient-Centered Care.
     Gastroenterology. 2026 May 25:S0016-5085(26)06931.
     PubMed    
     
     
     

130. KHASAWNEH M, Thakur ER, Goodoory VC, Moayyedi P, et al
     Efficacy of gut-brain neuromodulators and brain-gut behaviour therapies for irritable bowel syndrome: systematic review and network meta-analysis.
     Gut. 2026 Jun 26:gutjnl-2026-339311. doi: 10.1136/gutjnl-2026-339311.
     PubMed    
     Abstract available
     
     

131. MARTELLUCCI J, Orlandi S
     Management of bowel dysfunction after pelvic surgery for endometriosis.
     Int J Colorectal Dis. 2026 Jun 3. doi: 10.1007/s00384-026-05163.
     PubMed    
     Abstract available
     
     

132. MIHARA H, Matsuzaki J, Okugawa T, Oshima T, et al
     Methods to build and maintain effective clinician-patient relationships for adults with disorders of gut-brain interaction (DGBI): a systematic review.
     J Gastroenterol. 2026 Jun 21. doi: 10.1007/s00535-026-02467.
     PubMed    
     Abstract available
     
     

133. HE Y
     Re-Evaluating Probiotic Efficacy in Irritable Bowel Syndrome: A Call for Rigorous Statistics, Digital Therapeutics, and Microbiome-Driven Precision.
     J Gastroenterol Hepatol. 2026 May 29. doi: 10.1111/jgh.70459.
     PubMed    
     
     
     

134. LOH AJC, Loo QY, Ng AK, Khoo XH, et al
     Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
     J Gastroenterol Hepatol. 2026 Jun 3. doi: 10.1111/jgh.70477.
     PubMed    
     Abstract available
     
     

135. ZHU J, Qiu X, Ma R
     Comment on "Efficacy and Safety of Postbiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis".
     J Gastroenterol Hepatol. 2026 Jun 7. doi: 10.1111/jgh.70482.
     PubMed    
     
     
     

136. LI S, Lin K, Che K
     Comments on "Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance".
     J Gastroenterol Hepatol. 2026 Jun 24. doi: 10.1111/jgh.70530.
     PubMed    
     
     
     

137. AROOBA FNU, Hidayat A, Umar M
     "Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance" by Loh et al.
     J Gastroenterol Hepatol. 2026 Jun 21. doi: 10.1111/jgh.70528.
     PubMed    
     
     
     

138. XU L
     Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
     J Gastroenterol Hepatol. 2026 Jun 21. doi: 10.1111/jgh.70531.
     PubMed    
     
     
     

139. ZHUANG H
     Letter to the Editor: Reassessing Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: A Comparative Study of Diagnostic Guidelines and Their Clinical Relevance.
     J Gastroenterol Hepatol. 2026 Jun 19. doi: 10.1111/jgh.70516.
     PubMed    
     
     
     

140. DE BRUIJN CMA, Oorthuys AOJ, Zeevenhooven J, Davids M, et al
     Feasibility and efficacy of fecal microbiota transplantation in adolescents with refractory irritable bowel syndrome: A randomized clinical pilot trial.
     J Pediatr Gastroenterol Nutr. 2026 Jun 1. doi: 10.1002/jpn3.70459.
     PubMed    
     Abstract available
     
     

141. SPURNA Z, Fiser M, Macek M Jr, Schwarz M, et al
     A call for caution in expanding the mutational spectrum of SI gene deficiency.
     Scand J Gastroenterol. 2026 Jun 1:1-6. doi: 10.1080/00365521.2026.2681103.
     PubMed    
     Abstract available
     
     

142. PUODINKETO T, Elamo S, Koffert J, Niiranen T, et al
     Translation and validation of the Rome IV Functional Gastrointestinal Disease questionnaire for adults and prevalence of functional gastrointestinal disorders in the general Finnish population.
     Scand J Gastroenterol. 2026 Jun 1:1-5. doi: 10.1080/00365521.2026.2678596.
     PubMed    
     Abstract available
     
     

143. WONNEMANN M, Lipowicz B, Duysburgh C, Rotsaert C, et al
     Repeated dosing of myrrh, chamomile extract, and coffee charcoal reveals potential health-beneficial effects in patients with irritable bowel syndrome in the M-SHIME simulator.
     PLoS One. 2026;21:e0348791.
     PubMed    
     Abstract available
     
     

144. FEI Y, Gao MY, Qiao N, Hu J, et al
     Bioinformatic identification of CD8+ T cell activation mediated by key genes in fecal microbiota transplantation for irritable bowel syndrome.
     PLoS One. 2026;21:e0351574.
     PubMed    
     Abstract available
     
     

145. WILEMAN V, Czuber-Dochan W, Moss-Morris R, Dibley L, et al
     Supporting patients using a digital self-management intervention for symptoms of fatigue, pain, and urgency/incontinence in Inflammatory Bowel Disease: a mixed methods process evaluation of trial facilitators.
     PLoS One. 2026;21:e0350560.
     PubMed    
     Abstract available